FOST Switch

​

EVALUATING EFFICACY AND CONVENIENCE OF SWITCHING A BOOSTED PROTEASE INHIBITOR TO FOSTEMSAVIR IN PLWH WITH LIMITED THERAPEUTIC OPTIONS

​

Status:  Ongoing, Open to Recruitment

 

SPONSOR: NEAT ID Foundation 

 

Funded by: ViiV

​

Territories : UK, Italy, Spain

​

Publications: Poster Presentation, BHIVA 2025.

Title: Switching boosted protease inhibitor based antiretroviral therapy to fostemsavir + optimized background regimen in virally suppressed people with HIV with limited therapeutic options

​​

Main study abstract expected 2027, manuscript due late 2027. 

CSF sub-study abstract and manuscript due 2027. 

​

​